Piper Sandler confirms USD 59.00 target for CooperCompanies stock
Published on 10/20/2026 at 19:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and quarterly results
- Piper Sandler confirmed a USD 59.00 target and Neutral rating on October 15, 2026.
- Fiscal third-quarter 2026 revenue reached USD 1.066 billion, up 0.60 percent year over year.
- CooperCompanies stock costs EUR 52.35 at Lang & Schwarz on October 20, 2026 at 7:18 p.m. CEST.
CooperCompanies (ISIN US2166485019) is trading at EUR 52.35 at Lang & Schwarz on October 20, 2026 at 7:18 p.m. CEST. Piper Sandler confirmed a Neutral rating and a USD 59.00 price target on October 15, 2026, according to Investing.com. At the USD 58.84 primary-market quote on October 20, the target was 0.27 percent above the share price.
Revenue held near USD 1.066 billion
CooperCompanies reported fiscal third-quarter 2026 revenue of USD 1.066 billion, an increase of 0.60 percent from the year-earlier quarter. Adjusted earnings per share came to USD 1.15, 3.60 percent above the Zacks consensus estimate of USD 1.11, while GAAP earnings per share reached USD 2.24 after a USD 307.20 million discrete tax benefit.
Revenue missed the USD 1.099 billion consensus estimate by 3.00 percent. CooperVision revenue was USD 717.00 million and was flat year over year, while CooperSurgical revenue rose 2.00 percent to USD 349.20 million in the fiscal third quarter, according to Zacks Equity Research.
What does the USD 59.00 target imply?
Piper Sandler's October 15 rating leaves the target only 0.27 percent above the USD 58.84 primary-market quote. The contrast is sharper against the 52-week range of USD 51.01 to USD 89.83, which places the current quote USD 31.00 below the high and USD 7.83 above the low.
December 3 is the next date
Zacks Investment Research lists December 3, 2026 as the expected next earnings date and gives a consensus estimate of USD 1.11 for earnings per share. The company operates through CooperVision and CooperSurgical, serving vision care and women's health markets, according to CooperCompanies.
Price stays below the yearly high
The primary-market quote was USD 58.84 on Nasdaq at 1:27 p.m. ET on October 20, 2026, with a market capitalization of USD 11.2 billion and a P/E ratio of 20.07. Alcon traded at USD 67.69 with a P/E ratio of 52.06 and a market capitalization of USD 32.7 billion, while Becton, Dickinson and Company stood at USD 192.94 with a P/E ratio of 58.12 and a market capitalization of USD 52.6 billion on the same date.
CooperCompanies was trading at EUR 52.35 at Lang & Schwarz on October 20, 2026 at 7:18 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of CooperCompanies stock.
CooperCompanies stock facts
- Company: The Cooper Companies, Inc.
- ISIN: US2166485019
- Ticker: COO
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 20, 2026, 7:18 p.m. CEST): EUR 52.35
- Market capitalization: USD 11.2 billion (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
Market context: Market report S&P 500.
